U.S. Flow Cytometry Market Size & Outlook, 2023-2030
U.S. flow cytometry market, 2018-2030 (US$M)
Related Markets
U.S. flow cytometry market highlights
- The U.S. flow cytometry market generated a revenue of USD 1,613.3 million in 2023 and is expected to reach USD 2,609.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7.1% from 2024 to 2030.
- In terms of segment, instruments was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Flow cytometry market data book summary
| Market revenue in 2023 | USD 1,613.3 million |
| Market revenue in 2030 | USD 2,609.2 million |
| Growth rate | 7.1% (CAGR from 2023 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & Consumables, Software, Accessories, Services |
| Key market players worldwide | Danaher Corp, BD, Sysmex Corp, Agilent Technologies, Apogee Enterprises Inc, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Wipro Ltd ADR, Diasorin SpA, Miltenyi Biotec, Sony Group Corp |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.4% of the global flow cytometry market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. flow cytometry market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 292.7 million by 2030.
Instruments was the largest segment with a revenue share of 35.08% in 2023. Horizon Databook has segmented the U.S. flow cytometry market based on instruments, reagents & consumables, software, accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.
According to American Cancer Society’s estimates, in 2021, around 1.9 million new cases of leukemia are estimated to be diagnosed in the U.S., which is estimated to lead to around 608,570 deaths. In addition, following the outbreak of COVID‐19, several U.S.-based companies are involved in extensive research for development of novel vaccines and therapeutics.
Government support and funding to facilitate the development of novel flow cytometry solutions in the country are anticipated to create lucrative growth opportunities. For instance, in October 2019, the National Institutes of Health’s National Institute on Drug Abuse granted USD 1.5 million Phase II Small Business Innovation Research (SBIR) funds to U.S. based NanoCellect Biomedical, Inc. With this grant, the company continued the development of its flow cytometry technology.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Flow Cytometry Market Scope
Flow Cytometry Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. flow cytometry market size, by product, 2018-2030 (US$M)
U.S. Flow Cytometry Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
